Related references
Note: Only part of the references are listed.An investigation of the HIV Tat C31S and R57S mutation on peripheral immune marker levels in South African participants: A pilot study
Monray E. Williams et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment
Vurayai Ruhanya et al.
JOURNAL OF NEUROVIROLOGY (2022)
Plasma Cytokine Levels As Predictors of Global and Domain-Specific Human Immunodeficiency Virus-Associated Neurocognitive Impairment in Treatment-Naive Individuals
Vurayai Ruhanya et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2021)
Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV
Vurayai Ruhanya et al.
JOURNAL OF NEUROVIROLOGY (2020)
High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study
Megbaru Debalkie Animut et al.
PLOS ONE (2019)
Entropy and Information within Intrinsically Disordered Protein Regions
Iva Pritisanac et al.
ENTROPY (2019)
Vpr and Its Cellular Interaction Partners: R We There Yet?
Helena Fabryova et al.
CELLS (2019)
Datamonkey 2.0: A Modern Web Application for Characterizing Selective and Other Evolutionary Processes
Steven Weaver et al.
MOLECULAR BIOLOGY AND EVOLUTION (2018)
White matter fiber bundle lengths are shorter in cART naive HIV: an analysis of quantitative diffusion tractography in South Africa
Jodi M. Heaps-Woodruff et al.
BRAIN IMAGING AND BEHAVIOR (2018)
HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation
Manmeet K. Mamik et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status
Will Dampier et al.
JOURNAL OF NEUROVIROLOGY (2017)
Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity
Robert H. Paul et al.
JOURNAL OF NEUROVIROLOGY (2017)
Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria
Jibreel Jumare et al.
JOURNAL OF NEUROVIROLOGY (2017)
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
Will Dampier et al.
SCIENTIFIC REPORTS (2017)
Defining the roles for Vpr in HIV-1-associated neuropathogenesis
Tony James et al.
JOURNAL OF NEUROVIROLOGY (2016)
HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies
Rui Soares et al.
REVIEWS IN MEDICAL VIROLOGY (2016)
The High Cost of Fidelity
Sarah B. Lloyd et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions
Kevin Hadi et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment
Lilith Torres et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease
Robert H. Paul et al.
JOURNAL OF NEUROVIROLOGY (2014)
COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification
Daniel Struck et al.
NUCLEIC ACIDS RESEARCH (2014)
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)
Vasudev R. Rao et al.
AIDS RESEARCH AND THERAPY (2014)
Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways
Mohitkumar R. Gangwani et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival
Adriano Ferrucci et al.
JOURNAL OF NEUROVIROLOGY (2013)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Global analysis of sequence diversity within HIV-1 subtypes across geographic regions
Austin Huang et al.
FUTURE VIROLOGY (2012)
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
Hong Na et al.
RETROVIROLOGY (2011)
Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology
Wayne Delport et al.
BIOINFORMATICS (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles
Narasimhan J. Venkatachari et al.
VIROLOGY JOURNAL (2010)
HIV-1 Vpr deregulates calcium secretion in neural cells
Inna Rom et al.
BRAIN RESEARCH (2009)
Human immunodeficiency virus type 1 Vpr: functions and molecular interactions
Bizhan Romani et al.
JOURNAL OF GENERAL VIROLOGY (2009)
The Immunosuppressive Properties of the HIV Vpr Protein Are Linked to a Single Highly Conserved Residue, R90
Irina Tcherepanova et al.
PLOS ONE (2009)
Characterization of the Molecular Determinants of Primary HIV-1 Vpr Proteins: Impact of the Q65R and R77Q Substitutions on Vpr Functions
Guillaume Jacquot et al.
PLOS ONE (2009)
Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction
Hiroko Kitayama et al.
JOURNAL OF VIROLOGY (2008)
Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients
Elizabeth D. A. Wheeler et al.
JOURNAL OF NEUROVIROLOGY (2006)
Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo
D Rajan et al.
AIDS (2006)
Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients
D Mologni et al.
AIDS (2006)
The Vpr protein from HIV-1: distinct roles along the viral life cycle
E Le Rouzic et al.
RETROVIROLOGY (2005)
Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis
RJ Pomerantz
DNA AND CELL BIOLOGY (2004)
Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages
RX Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy
W Cavert et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
HIV-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis
MP Sherman et al.
VIROLOGY (2002)
Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome
BE Sawaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr
SP Singh et al.
JOURNAL OF VIROLOGY (2000)
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest
P Henklein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate
LM Mansky et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
